Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MIER JW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gollob, JA; Veenstra, KG; Mier, JW; Atkins, MB
      Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12

      JOURNAL OF IMMUNOTHERAPY
    2. Kim, PN; Jonasch, E; Mosterman, BC; Mier, JW; Janssen, RAJ
      Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade

      CELL GROWTH & DIFFERENTIATION
    3. Panka, DJ; Mano, T; Suhara, T; Walsh, K; Mier, JW
      Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    4. Kaser, A; Brandacher, G; Steurer, W; Kaser, S; Offner, FA; Zoller, H; Theurl, I; Widder, W; Molnar, C; Ludwiczek, O; Atkins, MB; Mier, JW; Tilg, H
      Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis

      BLOOD
    5. McDermott, DF; Mier, JW; Lawrence, DP; van den Brink, MRM; Clancy, MA; Rubin, KM; Atkins, MB
      A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin 2, and interferon alpha-2B in patients with metastatic melanoma

      CLINICAL CANCER RESEARCH
    6. Gollob, JA; Mier, JW; Veenstra, K; McDermott, DF; Clancy, D; Clancy, M; Atkins, MB
      Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response

      CLINICAL CANCER RESEARCH
    7. Gollob, JA; Veenstra, KG; Jyonouchi, H; Kelly, AM; Ferrieri, P; Panka, DJ; Altare, F; Fieschi, C; Casanova, JL; Frank, DA; Mier, JW
      Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections

      JOURNAL OF IMMUNOLOGY
    8. Kamphaus, GD; Colorado, PC; Panka, DJ; Hopfer, H; Ramchandran, R; Torre, A; Maeshima, Y; Mier, JW; Sukhatme, VP; Kalluri, R
      Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Vannier, E; Kaser, A; Atkins, MB; Fantuzzi, G; Dinarello, CA; Mier, JW; Tilg, H
      Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy

      EUROPEAN CYTOKINE NETWORK
    10. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    11. MCDERMOTT DF; TREHU EG; MIER JW; SORCE D; RAND W; RONAYNE L; KAPPLER K; CLANCY M; KLEMPNER M; ATKINS MB
      A 2-PART PHASE-I TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITHSOLUBLE (CHINESE-HAMSTER OVARY) INTERLEUKIN-1 RECEPTOR

      Clinical cancer research
    12. POTTER DA; TIRNAUER JS; JANSSEN R; CROALL DE; HUGHES CN; FIACCO KA; MIER JW; MAKI M; HERMAN IM
      CALPAIN REGULATED ACTIN REMODELING DURING CELL SPREADING (VOL 141, PG647, 1998)

      The Journal of cell biology
    13. POTTER DA; TIRNAUER JS; JANSSEN R; CROALL DE; HUGHES CN; FIACCO KA; MIER JW; MAKI M; HERMAN IM
      CALPAIN REGULATES ACTIN REMODELING DURING CELL SPREADING

      The Journal of cell biology
    14. JANSSEN RAJ; VEENSTRA KG; JONASCH P; JONASCH E; MIER JW
      RAS-INDUCED AND RAF-INDUCED DOWN-MODULATION OF NONMUSCLE TROPOMYOSIN ARE MEK-INDEPENDENT

      The Journal of biological chemistry
    15. ATKINS MB; ROBERTSON MJ; GORDON M; LOTZE MT; DECOSTE M; DUBOIS JS; RITZ J; SANDLER AB; EDINGTON HD; GARZONE PD; MIER JW; CANNING CM; BATTIATO L; TAHARA H; SHERMAN ML
      PHASE-I EVALUATION OF INTRAVENOUS RECOMBINANT HUMAN INTERLEUKIN-12 INPATIENTS WITH ADVANCED MALIGNANCIES

      Clinical cancer research
    16. JANSSEN RAJ; MIER JW
      TROPOMYOSIN-2 CDNA LACKING THE 3'-UNTRANSLATED REGION RIBOREGULATOR INDUCES GROWTH-INHIBITION OF V-KI-RAS-TRANSFORMED FIBROBLASTS

      Molecular biology of the cell
    17. DUBOIS JS; TREHU EG; MIER JW; SHAPIRO L; EPSTEIN M; KLEMPNER M; DINARELLO C; KAPPLER K; RONAYNE L; RAND W; ATKINS MB
      RANDOMIZED PLACEBO-CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH A SOLUBLE P75 TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOGLOBULIN-G CHIMERA IN PATIENTS WITH ADVANCED MELANOMA AND RENAL-CELL CARCINOMA

      Journal of clinical oncology
    18. TREHU EG; MIER JW; DUBOIS JS; SORCE D; KLEMPNER MS; EPSTEIN M; DINARELLO CA; SHAPIRO L; KAPPLER K; RONAYNE L; ATKINS MB
      PHASE-I TRIAL OF INTERLEUKIN-2 IN COMBINATION WITH THE SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR P75 IGG CHIMERA

      Clinical cancer research
    19. SIKORSKI MA; STAUNTON DE; MIER JW
      L-SELECTIN CROSS-LINKING INDUCES INTEGRIN-DEPENDENT ADHESION - EVIDENCE FOR A SIGNALING PATHWAY INVOLVING PTK BUT NOT PKC

      Cell adhesion and communication
    20. STODDART JH; JASUJA RR; SIKORSKI MA; VONANDRIAN UH; MIER JW
      PROTEASE-RESISTANT L-SELECTIN MUTANTS - DOWN-MODULATION BY CROSS-LINKING BUT NOT CELLULAR ACTIVATION

      The Journal of immunology
    21. TIRNAUER JS; JANSSEN R; HUGHES CN; MIER JW; CROALL DE; MAKI M; HERMAN IM; POTTER DA
      CALPAIN REGULATES FUNCTION AND MORPHOLOGY OF THE ACTIN CYTOSKELETON

      Blood
    22. TILG H; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING INTERLEUKIN-10 BY INTERLEUKIN-1 AND INTERLEUKIN-2, BUT NOT INTERLEUKIN-6 IMMUNOTHERAPY

      Cytokine
    23. RYAN CM; ATKINS MB; MIER JW; GELFAND JA; TOMPKINS RG
      EFFECTS OF MALIGNANCY AND INTERLEUKIN-2 INFUSION ON GUT MACROMOLECULAR PERMEABILITY

      Critical care medicine
    24. ATKINS MB; KAPPLER K; MIER JW; ISAACS RE; BERKMAN EM
      INTERLEUKIN-6-ASSOCIATED ANEMIA - DETERMINATION OF THE UNDERLYING MECHANISM

      Blood
    25. SPARANO JA; FISHER RI; WEISS GR; MARGOLIN K; ARONSON FR; HAWKINS MJ; ATKINS MB; DUTCHER JP; GAYNOR ER; BOLDT DH; DOROSHOW JH; ERNEST ML; SZNOL M; MIER JW
      PHASE-II TRIALS OF HIGH-DOSE INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN ADVANCED BREAST-CARCINOMA AND CARCINOMA OF THE LUNG, OVARY, AND PANCREAS AND OTHER TUMORS

      Journal of immunotherapy with emphasis on tumor immunology
    26. MARGOLIN K; ARONSON FR; SZNOL M; ATKINS MB; GUCALP R; FISHER RI; SUNDERLAND M; DOROSHOW JH; ERNEST ML; MIER JW; DUTCHER JP; GAYNOR ER; WEISS GR
      PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA

      Journal of immunotherapy with emphasis on tumor immunology
    27. TILG H; TREHU E; SHAPIRO L; PAPE D; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR AND INTERLEUKIN-1 RECEPTOR ANTAGONIST FOLLOWING INTERLEUKIN-1-ALPHA INFUSION IN HUMANS

      Cytokine
    28. ATKINS MB; OBOYLE KR; SOSMAN JA; WEISS GR; MARGOLIN KA; ERNEST ML; KAPPLER K; MIER JW; SPARANO JA; FISHER RI; ECKARDT JR; PEREIRA C; ARONSON FR
      MULTIINSTITUTIONAL PHASE-II TRIAL OF INTENSIVE COMBINATION CHEMOIMMUNOTHERAPY FOR METASTATIC MELANOMA

      Journal of clinical oncology
    29. TILG H; SHAPIRO L; VANNIER E; POUTSIAKA DD; TREHU E; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING ANTAGONISTS TO IL-1 AND TNF BY IL-2 ADMINISTRATION AND THEIR EFFECTS ON IL-2-INDUCED CYTOKINE PRODUCTION IN-VITRO

      The Journal of immunology
    30. TILG H; TREHU E; ATKINS MB; DINARELLO CA; MIER JW
      INTERLEUKIN-6 (IL-6) AS AN ANTIINFLAMMATORY CYTOKINE - INDUCTION OF CIRCULATING IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-P55

      Blood
    31. TREHU EG; ISNER JM; MIER JW; KARP DD; ATKINS MB
      POSSIBLE MYOCARDIAL TOXICITY ASSOCIATED WITH INTERLEUKIN-4 THERAPY

      Journal of immunotherapy with emphasis on tumor immunology
    32. SPARANO JA; FISHER RI; SUNDERLAND M; MARGOLIN K; ERNEST ML; SZNOL M; ATKINS MB; DUTCHER JP; MICETICH KC; WEISS GR; DOROSHOW JH; ARONSON FR; RUBINSTEIN LV; MIER JW
      RANDOMIZED PHASE-III TRIAL OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 EITHER ALONE OR IN COMBINATION WITH INTERFERON ALFA-2A IN PATIENTS WITH ADVANCED MELANOMA

      Journal of clinical oncology
    33. BRANDON EP; KOTIK AN; VACHINO G; SWACK JA; LIBBY P; JANICKA MW; ATKINS MB; MIER JW
      CULTURED HUMAN ENDOTHELIAL-CELLS EXPRESS THE 140-KD ISOFORM OF NEURALCELL-ADHESION MOLECULE (NCAM)

      International journal of immunopathology and pharmacology
    34. TILG H; SHAPIRO L; ATKINS MB; DINARELLO CA; MIER JW
      INDUCTION OF CIRCULATING AND ERYTHROCYTE-BOUND IL-8 BY IL-2 IMMUNOTHERAPY AND SUPPRESSION OF ITS IN-VITRO PRODUCTION BY IL-1-RECEPTOR ANTAGONIST AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) CHIMERA

      The Journal of immunology
    35. GRANOWITZ EV; PORAT R; MIER JW; ORENCOLE SF; KAPLANSKI G; LYNCH EA; YE K; VANNIER E; WOLFF SM; DINARELLO CA
      INTRAVENOUS ENDOTOXIN SUPPRESSES THE CYTOKINE RESPONSE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF HEALTHY HUMANS

      The Journal of immunology
    36. TILG H; MIER JW; VOGEL W; AULITZKY WE; WIEDERMANN CJ; VANNIER E; HUBER C; DINARELLO CA
      INDUCTION OF CIRCULATING IL-1 RECEPTOR ANTAGONIST BY IFN TREATMENT

      The Journal of immunology
    37. TILG H; PAPE D; TREHU E; SHAPIRO L; ATKINS MB; DINARELLO CA; MIER JW
      A METHOD FOR THE DETECTION OF ERYTHROCYTE-BOUND INTERLEUKIN-8 IN HUMANS DURING INTERLEUKIN-1 IMMUNOTHERAPY

      Journal of immunological methods
    38. TILG H; VANNIER E; VACHINO G; DINARELLO CA; MIER JW
      ANTIINFLAMMATORY PROPERTIES OF HEPATIC ACUTE-PHASE PROTEINS - PREFERENTIAL INDUCTION OF INTERLEUKIN-1 (IL-1) RECEPTOR ANTAGONIST OVER IL-1-BETA SYNTHESIS BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      The Journal of experimental medicine
    39. GRANOWITZ EV; PORAT R; MIER JW; ORENCOLE SF; CALLAHAN MV; CANNON JG; LYNCH EA; YE K; POUTSIAKA DD; VANNIER E; SHAPIRO L; PRIBBLE JP; STILES DM; CATALANO MA; WOLFF SM; DINARELLO CA
      HEMATOLOGIC AND IMMUNOMODULATORY EFFECTS OF AN INTERLEUKIN-1 RECEPTORANTAGONIST COINFUSION DURING LOW-DOSE ENDOTOXEMIA IN HEALTHY HUMANS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/11/20 alle ore 03:37:39